INTRODUCTION
PFK (6-phosphofructo-1-kinase; EC 2.7.1.11) is a key regulatory enzyme in the glycolytic pathway, converting Fru-6-P (fructose 6-phosphate) into Fru-1,6-P 2 (fructose 1,6-bisphosphate). The mammalian enzyme is controlled by a variety of allosteric effectors, including the inhibitors ATP and citrate, and the activators AMP and ADP [1] . The most potent activator is Fru-2,6-P 2 (fructose 2,6-bisphosphate), which is especially important in the reciprocal control of glycolysis and gluconeogenesis in the liver, as Fru-2,6-P 2 also inhibits the opposing gluconeogenic enzyme fructose-1,6-bisphosphatase [2] . PFK from eukaryotic cells is composed of two highly homologous N-and C-terminal domains, which are thought to have resulted from duplication, fusion and divergence of an ancestral prokaryotic gene. This evolutionary process would lead to the formation of new regulatory binding sites. Thus the site for the allosteric activator Fru-2,6-P 2 is suggested to derive from the Fru-6-P catalytic site in the duplicated bacterial repeat, the two sites being located in the interface between the subunits of a dimer [3] .
However, an original proposal was that, in the eukaryotic enzyme, the chains were orientated in an antiparallel manner, such that the active site was in the interface between an Nterminal half and an adjacent C-terminal half, using amino acid residues from both, and similarly for the Fru-2,6-P 2 binding [3] [4] [5] . On the other hand, our previous work with site-directed mutagenesis showed that key residues for the active site were in the N-terminus, whereas key residues for the Fru-2,6-P 2 site were in the C-terminus, suggesting a N-terminal/N-terminal-Cterminal/C-terminal interaction of adjacent chains [6] . This model is consistent with the recent reports of the electron microscopy structure of human muscle PFK [7] and the crystal structures of the enzymes from the yeasts Pichia pastoris [8] and Saccharomyces cerevisiae [9] . In the present paper we describe conclusive evidence that the N-terminal half, by itself, is capable of forming a functional PFK active site. We expressed several truncated forms of the enzymes from DdPFK (Dyctiostelium discoideum PFK) ( Figure 1 ) and human muscle (HmPFK) in a PFK-deficient strain of S. cerevisiae. We chose the non-allosteric DdPFK for most of the present study to take advantage of its much greater stability and ease of purification [11] . The C-terminus is not catalytic, but it is needed for stability of the enzyme, as is the connecting peptide that joins the two domains.
EXPERIMENTAL

Materials
All chemical reagents and enzymes used in genetic assays and protein purification were obtained from Roche, GE Healthcare or Sigma. Auxiliary enzymes and biochemicals for the PFK assay were from Sigma. Oligonucleotides were synthesized by
Strains, media and growth conditions
The Escherichia coli strain DH5α [SupE44 lacU169 (ϕ80 lacZ M15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1] was used for general cloning procedures and amplification of DNA. E. coli was grown at 37
• C in either liquid or solid LB (LuriaBertani) media [12] [13] ). Yeast strains were grown at 30
• C in YPD medium [1 % (w/v) yeast extract, 1 % (w/v) peptone and 2 % (w/v) glucose] or in minimal medium containing 0.67 % YNB (yeast nitrogen base; Difco), 2 % (w/v) of the carbon sources indicated in each case, and substances needed for the auxotrophic strain used at concentrations given previously [14] . Liquid cultures were shaken at 200 rev./min in a New Brunswick orbital shaker. Solid media were identical, but with 2 % (w/v) agar added. Transformation of S. cerevisiae was performed as described in Klebe et al. [15] , with the modifications introduced by Dohmen et al. [16] . Yeast generation times were measured by following the D 600 .
Molecular biology techniques and plasmid construction
Recombinant DNA manipulations were carried out as described previously [12] . N-terminal-and C-terminal-truncated genes of DdPFK, and HmPFK-M were constructed by PCR amplification [17] , using either the pJJH71 derivative pBE 0 [11] carrying the cDNA for DdPFK or the plasmid pJJH71PFK [18] containing HmPFK-M cDNA, as the template, and the mutagenic oligonucleotides indicated in Supplementary Table S1 (at http://www.BiochemJ.org/bj/445/bj4450213add.htm) in combination with the appropriate primer at either the 5 or 3 ends of DdPFK and HmPFK-M cDNAs. PCR products digested with appropriate endonucleases were cloned into pJJH71 [18] , yielding the expression plasmids for the truncated proteins. For the coexpression of the N-and C-termini of PFK, plasmids expressing the C-terminal ends were constructed by cloning the HindIIIdigested fragments of the corresponding pJJH71 derivatives into pGAD424 (Clontech/Takara Bio Europe). The chimaeric gene for ChiDdM-PFK (chimaeric PFK composed of the N-terminal half of DdPFK and the C-terminal half of HmPFK-M) was created by digesting the PCR product that contains the 5 region of the DdPFK gene with BamHI and DraIII and its simultaneous cloning with the DraIII/SphI-digested fragment from pJJH71PFK into BamHI-SphI sites of the expression vector pJJH71. In this way, the DdPFK gene up to codon 436 was grafted in-frame on to the HmPFK-M gene beginning at the codon for His 401 . Similarly, the chimaeric gene for ChiMDd-PFK (chimaeric PFK composed of the N-terminal half of HmPFK-M and the C-terminal half of DdPFK) was generated by ligation of the DraIII/SphIdigested PCR product carrying the 3 region of the DdPFK gene and the BamHI-DraIII fragment obtained from pJJH71PFK into BamHI-SphI sites of pJJH71. The resulting plasmid contained the HmPFK-M gene up to the codon for Val 403 in-frame with the DdPFK gene starting at codon 437. Sequence integrity of the plasmid constructs was confirmed by DNA sequencing. For expression of wild-type DdPFK and HmPFK-M in yeast, the plasmids pBE 0 and pJJH71PFK were used.
Expression and purification of recombinant enzymes
N-term represents transformants expressing the sequence of the N-terminal half and C-term represents transformants expressing the sequence for the C-terminal half of PFK. For the production N-term and C-term, the yeast strain HD152-1D transformed with the corresponding pJJH71 and pGAD424 derivatives was grown to stationary phase in 2 litres of YNB medium with 2 % glucose. For purification of the recombinant enzyme, first fractionation on 10 % (w/v) poly(ethylene glycol) and chromatography on DE52 and Blue-Sepharose CL-6B was carried out as described previously [19] , except that PFK activity was eluted from the latter column with a 100 ml linear gradient of 0-1.5 M KCl in equilibration buffer [50 mM Hepes, 5 mM MgCl 2 , 2 mM EDTA, 1 mM dithiothreitol, 0.5 mM PMSF and 20 % (w/v) glycerol, pH 6.8]. The dialysed Blue-Sepharose PFK fraction was then applied to a phosphocellulose column, this chromatographic step being performed as described in [20] . Fractions showing the highest PFK activity were pooled, concentrated 20-fold in dialysis tubing placed in powder poly(ethylene glycol) 6000, and subjected to FPLC size-exclusion chromatography on a Superdex TM 200HR 10/30 column equilibrated with 50 mM sodium phosphate buffer, 150 mM NaCl and 10 mM Fru-6-P (pH 7.0) [21] . The recombinant PFK from yeast expressing the N-and C-terminal regions of HmPFK-M was purified from yeast transformants grown to stationary phase in 2 litres of YNB medium with 2 % glucose by chromatography on BlueSepharose CL-6B and DEAE-trisacryl performed as described previously [17] . Wild-type DdPFK and HmPFK-M were purified as described previously [11, 17] . The protein concentration was determined by Bradford's dye-binding method [22] , using bovine γ -globulin as the standard.
PFK activity assay
Total PFK activity was measured as described previously [17] . Assays for kinetic studies were carried out at pH 7.0 in 50 mM Hepes, 100 mM KCl, 5 mM MgCl 2 , 0.15 mM NADH, 1.2 units of aldolase, 10 units of triosephosphate isomerase, 1 unit of glycerol-3-phosphate dehydrogenase, 2-5 μl of the purified enzyme, and the indicated concentrations of MgATP, effector and Fru-6-P in a final volume of 1 ml. In all cases, the reaction was started after a 5 min pre-incubation by the addition of Fru-6-P, and was followed by measuring the absorbance change at 340 nm at 25
• C. When PFK activity was assayed during purification, glucose 6-phosphate was added to Fru-6-P at a proportion of 3:1 (mol/mol). Auxiliary enzymes were desalted as described previously [20] . One unit of activity is defined as the amount of enzyme that catalyses the conversion of 1 μmol of substrate/min under the above conditions. Kinetic data are the average of a minimum of three measurements. The standard error did not exceed 10 % of the average value. Parameters were determined using Origin version 7.0 software programmed to fit data to either the Hill or the Michaelis-Menten equation.
Electrophoretic and immunological analysis
SDS/PAGE (10 % gels), Coomassie Blue staining and Western blot analysis were carried out as described previously [20] . Antiserum against DdPFK [20] or HmPFK-M, and the horseradish-peroxidase-conjugated secondary antibody were used at 1:3000 and 1:5000 dilutions respectively. Immunostaining was performed either as described by Martínez-Costa et al. [20] or with an ECL (enhanced chemiluminescense) detection technique [23] . ELISA analyses of FPLC size-exclusion chromatography fractions were performed as described previously [24] , using a 1:10 000 dilution of primary antibodies.
Glucose and ethanol measurements
To measure glucose consumption and ethanol production, yeast cells grown in YPD medium were collected during the exponential phase of growth, resuspended at 40 mg (wet weight)/ml in fresh medium containing 2 % glucose, and incubated with shaking at 30
• C. Culture samples were taken at the indicated time, centrifuged at 3000 g for 1 min, and ethanol and glucose in the medium were measured by standard enzymatic techniques [25] .
RESULTS
We found that the N-terminal half of DdPFK corrected the inability of the PFK-deficient recipient strain to grow on glucose, whereas the C-terminal half was ineffective (Figure 2 ). Western blot analysis confirmed the presence of truncated N-or C-termini in the respective transformants ( Figure 3A) . Yeast transformants expressing the N-terminus were indeed able to ferment glucose (Figure 4) , thus demonstrating that this domain was sufficient to generate an active enzyme in intact cells. In fact, the N-terminal half was able to maintain nearly normal glucose metabolism in vivo. Thus yeast transformants expressing the N-terminus consumed glucose and produced ethanol at rates that were nearly 35 % of those of transformants expressing wild-type DdPFK (Figure 4, inset) . The stoichiometric ethanol/glucose ratio (1.7) was similar in both cases and similar also to that shown by the isogenic untransformed strain VW1a which is wild-type for the yeast PFK genes. The glucose fermentation flux in the latter was approximately half of that of the HD152-1D strain expressing wild-type DdPFK, perhaps in part because of the non-allosteric hyperbolic nature of DdPFK [11, 20] compared with the allosteric yeast PFK, which is thus subject to regulation in vivo [26] . The N-terminal half of DdPFK was, however, extremely unstable when assayed in a cellfree extract, rapidly becoming inactive (Supplementary Figure  S1 at http://www.BiochemJ.org/bj/445/bj4450213add.htm). Sizeexclusion chromatography showed that the N-terminus aggregated in cell extracts into (inactive) forms higher than octamers (equivalent to the native enzyme tetramer) ( Figure 3B ).
These findings are consistent with our hypothesis that the catalytic sites of eukaryotic PFK are restricted to the N-terminal half, which is capable of achieving a functional conformation in vivo reminiscent of the prokaryotic enzyme. Co-expression of the two terminal halves improved the growth of transformants, compared with expression of the N-terminus alone (Supplementary Figure  S2 at http://www.BiochemJ.org/bj/445/bj4450213add.htm). Furthermore, co-expression of the two terminal halves generated a stable fully active enzyme that could be purified to homogeneity §K act , effector concentration at half-maximal activation. These values were obtained at Fru-6-P concentrations equal to the S 0.5 (Fru-6-P) values and 5 mM MgATP, pH 7.0.
Inhibitory MgATP concentrations were used to demonstrate the elevated S 0.5 and n H for Fru-6-P, and also Fru-2,6-P 2 activation of the mammalian enzyme. and was shown to adopt an octameric form of a molecular mass equivalent to that of the native enzyme ( Figure 5A) ; the two terminal components being present in similar amounts as visualized by SDS/PAGE ( Figure 5B ). Therefore the oligomer was composed of four 'N-terminal subunits' and four 'C-terminal subunits', presumably organized into a conformation analogous to that of the tetrameric wild-type enzyme. The purified PFK activity obtained by co-expression of the two terminal halves of DdPFK exhibited kinetic properties similar to those of the wildtype enzyme (Table 1) .
Similar results were obtained upon co-expression of the terminal halves of HmPFK-M, which also generated an active enzyme in vitro that furthermore exhibited binding at ATP and Fru-2,6-P 2 regulatory sites comparable with that of the intact N-(1-370) ] or the C-terminal half (C-term and pC-term) of DdPFK were grown on different carbon sources as described in the legend to Figure 2 . N-term and N-(1-370) contained the 436 and the 370 N-terminal residues from DdPFK respectively, whereas C-term and pC-term contained the 395 and the 464 C-terminal residues from this enzyme respectively; thus, the connecting peptide between PFK domains was present only in the N-term and pC-term deletions (see Figure 1) . enzyme ( Figure 5B and Table 1 ), whereas expression of the Nterminus alone yielded an active enzyme in vivo, but not in vitro. The N-terminal half of HmPFK-M was even more unstable in cellfree extracts than that of DdPFK (Supplementary Figure S1) . It is worth noting that the hardly detectable activity of the N-terminus of HmPFK-M was not modified by the addition of 10 μM Fru-2,6-P 2 . This is consistent with the fructose bisphosphate allosteric site being located in the C-terminal half of the enzyme [6] . Stability of the N-terminal half was not improved by addition of 10 % poly(ethylene glycol), which increases the local concentration of the protein [27] .
These results indicate that the C-terminal half of eukaryotic PFK, although devoid of a catalytic function, is essential for the enzyme to reach a stable tetrameric conformation. Interestingly, co-expression of the heterologous terminal domains (the DdPFK N-terminus with the HmPFK C-terminus, or the HmPFK N-terminus with the DdPFK C-terminus) did not lead to stable activity in vitro. Even chimaeric PFKs, involving exchange of the N-and C-terminal halves of DdPFK and HmPFK-M, did not produce stable activity in vitro. Of the two chimaeric constructs, only ChiDdM-PFK was able to complement the glucose-negative phenotype of the recipient yeast strain, producing an immunologically detectable protein of the expected size (Supplementary Figure S3 at http://www.BiochemJ.org/bj/445/bj4450213add.htm). Although this chimaeric enzyme was inactive in vitro, a significant proportion of it was able to organize into tetramers ( Supplementary Figure S4 at http://www.BiochemJ.org/bj/445/bj4450213add.htm), like native PFKs. The other chimaeric construct ChiMDd-PFK apparently did not lead to sufficient active enzyme in vivo, indicating that a mismatched C-terminus can even destabilize the N-terminus.
The truncated N-terminal protein included the peptide that connects the two PFK domains in the native enzyme (residues 371-435). We therefore also examined the importance of this region. Expression of the N-terminus lacking the connecting peptide, N-(1-370), whether co-expressed with a C-terminus either lacking this peptide (C-term) or containing this peptide at its N-terminal end (pC-term), did not restore growth on glucose ( Figure 6 ). Even partial deletions of the connecting peptide on the N-terminus [N- and N-(1-420)] prevented the generation of functionally active enzyme (Supplementary Figure S5 at http://www.BiochemJ.org/bj/445/bj4450213add.htm). These results indicate that the peptide which connects the two terminal domains of eukaryotic PFK is essential for the production of a stable catalytic protein. Interestingly, C-term was no longer detected when co-expressed with N-(1-370).
DISCUSSION
A major conclusion of the present study is that the catalytic site of PFK is contained in the N-terminal half, with no necessary participation of C-terminal residues. This was conclusively shown by the restoration of growth on glucose in PFK-deficient yeast upon expression of the N-terminal half alone, whereas no growth was elicited by expression of the C-terminal half. This agrees with our previous studies with site-directed mutagenesis of key residues in the two halves [6] . Since the catalytic site is in the interface between subunits in a dimer, with residues contributed from both subunits, this indicates that subunits associate within a dimer by each terminal half binding to its equivalent one in the adjacent subunit. This conclusion is also consistent with the electron microscopy structure of human muscle PFK [7] and the crystal structures of the enzymes from the yeasts P. pastoris [8] and S. cerevisiae [9] . A similar assembly of the enzyme dimer can be inferred from the crystal structure of rabbit muscle PFK [9] . However, the N-terminal half by itself was extremely unstable when assayed in a cell-free extract, rapidly becoming inactive, which thus prevented further kinetic studies. Recently Smerc et al. [28] reported that expression of a longer N-terminal fragment of HmPFK-M (residues 1-443, including the first 40 amino acids of the C-terminus) in a PFK-null E. coli strain allowed growth on glucose and produced a truncated enzyme that was also extremely unstable in vitro. In the present study we show that co-expression of the C-terminal half, together with the N-terminal half, yielded enzyme activity that was stable in vitro. This was true both for the non-allosteric DdPFK and for the allosteric mammalian HmPFK-M, thus indicating also that, despite its lack of most regulatory properties characteristic of eukaryotic PFK, the D. discoideum enzyme has a similar functional structure, with similar stabilizing interactions. This is consistent with the similar tetrameric organization for DdPFK, as suggested by electron microscopy analysis [7] . The underlying similarity is also supported by the interesting observation that deletion or mutation of the last C-terminal residue of DdPFK can convert it into an allosteric enzyme [11] .
The fact that co-expression of the two terminal halves of PFK resulted in a fully active enzyme in vitro, with physical, kinetic and regulatory properties similar to those of the native enzyme ( Figure 5 and Table 1 ), also shows that the interdomain interactions are strong enough to maintain the tetramer together, even after splitting of the connecting peptide, with preservation of the metabolite binding sites located at the corresponding interfaces. These results are consistent with the early observation by Emerk and Frieden [29] that trypsin treatment of muscle PFK gave two species of molecular masses 42 000 and 48 000 Da, without alteration of the regulatory characteristics of the enzyme. However, the situation in the present study is even more extreme, indicating that the separately translated domains can fold sufficiently well to bind to each other, that such binding of complementary domains is stable and that the alignment is sufficiently accurate and tight as to preserve allosteric interactions.
Interestingly, this stabilization effect was only seen with complementary enzyme halves; that is, heterologous expression of the DdPFK N-terminus with the HmPFK C-terminus, or the HmPFK N-terminus with the DdPFK C-terminus, did not produce a stable enzyme in vitro. Even linked chimaeric forms did not produce a stable enzyme in vitro, and one (the N-terminus of HmPFK-M linked to the C-terminus of DdPFK HmPFK-M) was not even active in vivo, indicating that the covalent attachment of a mismatched C-terminus could even destabilize an N-terminal half that was otherwise functional in vivo. In contrast, we previously reported studies of stable chimaeric forms of the mammalian isoforms PFK-M and PFK-C [30] . Thus the C-terminal domain appears to stabilize the whole enzyme to a substantial extent only when in combination with the N-terminal domain from either the same protein or from an evolutionarily close isoenzyme. This role of the C-terminal domain to stabilize the enzyme is, of course, in addition to its role in providing allosteric regulatory sites. Furthermore, the C-termini may provide the contact surfaces for the interaction between dimers within the tetramer, as proposed by the electron microscopy three-dimensional reconstruction of HmPFK-M [7] and shown in the crystal structure of the enzyme from P. pastoris [8] .
The connecting peptide [DdPFK-(371-435)] is an essential part of the N-terminus. The most probable cause for the lack of production of an N-terminal protein functionally active in vivo when the connecting peptide was deleted is that an α-helix which was shown to be essential for the stability of the bacterial enzyme [31] and PFK-M (a mutation in PFK-M from dogs disrupted this helix) [32] , and which is apparently conserved in DdPFK, was eliminated by either partial or complete deletion of the connecting peptide. N-(1-370) could not be complemented by co-transfection with the C-terminus with added peptide (pC-term). The simplest explanation would be inadequate folding of N-(1-370) so that it could not interact with pC-term. However, co-expression of N-(1-370) together with C-term eliminated C-terminal protein that was observed when C-term was expressed alone. This suggests some sort of association of the two subunits in a conformation recognized as damaged, such that both are then degraded, perhaps through joint ubiquitination or acetylation.
In conclusion, the present study shows the distinct roles of the two terminal halves of eukaryotic PFK. The N-terminal half contains the catalytic site, in agreement with the higher similarity of this region to the prokaryotic enzyme [3] . The evolutionarily added C-terminal half stabilizes the enzyme by promoting formation of the eukaryotic tetrameric structure, in addition to accommodating extra metabolite binding sites for the more complex regulation in eukaryotic cells. Figure 3 of the main paper) is shown as a broken line for comparison. ChiDdM-PFK eluted in three peaks (᭹). Of this, 26 % of the eluted protein was calculated to be in a tetrameric form (second peak), the remaining protein either aggregated into forms larger than tetramers (first peak) or dissociated to monomers (third peak). Yeast cells co-transformed with plasmids each carrying a different portion of the N-terminal or the C-terminal half of DdPFK were grown on different carbon sources as described in the legend to Figure 2 of the main paper. N-term and C-term contained the 436 N-terminal residues and the 395 C-terminal residues from DdPFK respectively, residues contained in the other N-terminal deletions are indicated by numbers (see Figure 1 of the main paper). 
